Piciu, F.; Domocos, D.; Chiritoiu, G.; Chiritoiu-Butnaru, M.; Mernea, M.; Popescu, C.G.; Mihai, D.P.; Galateanu, B.; Hudita, A.; Babes, A.;
et al. Transient Receptor Potential Ankyrin 1 (TRPA1) Modulation by 4-Hydroxynonenal (4-HNE) in Pancreatic Adenocarcinoma Cell Lines: Putative Roles for Therapies. Pharmaceuticals 2024, 17, 344.
https://doi.org/10.3390/ph17030344
AMA Style
Piciu F, Domocos D, Chiritoiu G, Chiritoiu-Butnaru M, Mernea M, Popescu CG, Mihai DP, Galateanu B, Hudita A, Babes A,
et al. Transient Receptor Potential Ankyrin 1 (TRPA1) Modulation by 4-Hydroxynonenal (4-HNE) in Pancreatic Adenocarcinoma Cell Lines: Putative Roles for Therapies. Pharmaceuticals. 2024; 17(3):344.
https://doi.org/10.3390/ph17030344
Chicago/Turabian Style
Piciu, Florentina, Dan Domocos, Gabriela Chiritoiu, Marioara Chiritoiu-Butnaru, Maria Mernea, Cezar Gabriel Popescu, Dragos Paul Mihai, Bianca Galateanu, Ariana Hudita, Alexandru Babes,
and et al. 2024. "Transient Receptor Potential Ankyrin 1 (TRPA1) Modulation by 4-Hydroxynonenal (4-HNE) in Pancreatic Adenocarcinoma Cell Lines: Putative Roles for Therapies" Pharmaceuticals 17, no. 3: 344.
https://doi.org/10.3390/ph17030344
APA Style
Piciu, F., Domocos, D., Chiritoiu, G., Chiritoiu-Butnaru, M., Mernea, M., Popescu, C. G., Mihai, D. P., Galateanu, B., Hudita, A., Babes, A., & Cucu, D.
(2024). Transient Receptor Potential Ankyrin 1 (TRPA1) Modulation by 4-Hydroxynonenal (4-HNE) in Pancreatic Adenocarcinoma Cell Lines: Putative Roles for Therapies. Pharmaceuticals, 17(3), 344.
https://doi.org/10.3390/ph17030344
